London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

Health experts have worried for some time what might happen if a new form of gonorrhea develops that doesn’t respond to our ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

"The approval of Blujepa is a crucial milestone with uUTIs among the most common infections in women," said GSK's chief scientific offer Tony Wood, pointing out that around 16 million women in the ...

A federal panel of medical experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination ...

The S&P 500 rose 0.13% to close at 5,282.70 on Thursday (April 17) after a volatile trading session, though the index still ...

1 PHILADELPHIA, March 25, 2025--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 ...

A pill developed by GSK was found to be safe and effective in ... The drug is sold under the name Blujepa. A new treatment option is important, experts say, because bacteria that commonly cause ...